Evaluate gives you the understanding and time you need to drive better decisions
Evaluate's beginning focused on providing consensus forecasts that distilled the insight of pharmaceutical equity analysts around the world. These are still the foundation of our services. Get up-to-date, robust forecasts aggregating a wealth of equity analyst research into a single standardised source. Ensure your analysis reaches the crux of the matter. From an overview of the broader market to a detailed product or company analysis, Evaluate's integrated platform is designed to take you from exploration to full understanding as quickly and accurately as possible.
Get a global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2024 and the first single view of the risk and return of the R&D landscape from EvaluatePharma Vision.
Get commercial intelligence on predicted global performance to 2024 and beyond with consensus forecasts and integrated analysis for the medical device and diagnostic industry.
Improve your strategic decision-making with customised solutions that draw on our team of industry experts and trusted commercial intelligence.
“ Evaluate is not a package I can do without... It's an absolute timesaver, and if you're saving time you're saving money. ”
“ Evaluate makes it possible for us to assess the commercial value for different products, as well as understand the major trends in the pharmaceutical industry. ”